Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of protease inhibitors and antiviral agents. Its structure supports enhanced metabolic stability and bioavailability in drug candidates. Commonly employed in medicinal chemistry for constructing beta-amino acid derivatives with improved pharmacokinetic profiles. Also utilized in the preparation of small-molecule inhibitors targeting enzymes involved in neurological and metabolic disorders.